Rocket Pharmaceuticals (RCKT) Convertible Debt (2015 - 2021)
Rocket Pharmaceuticals (RCKT) posted Convertible Debt of $35.5 million for Q1 2021, up 1.36% sequentially from $35.1 million in Q4 2020, and down 22.38% YoY from $45.8 million in Q1 2020.
Rocket Pharmaceuticals (RCKT) Convertible Debt (2015 - 2021) Analysis & Trends
Rocket Pharmaceuticals has reported Convertible Debt for 7 years, with the latest figure at $35.5 million in Q1 2021.
- Quarterly Convertible Debt fell 22.38% year-over-year to $35.5 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $35.5 million (down 22.38% YoY) and the FY2020 annual result came in at $35.1 million, down 22.16% from the prior year.
- Convertible Debt grew to $35.5 million in Q1 2021 per RCKT's latest filing, from $35.1 million in the prior quarter.
- Over five years, Convertible Debt peaked at $49.4 million in Q3 2017 and troughed at $35.1 million in Q4 2020.
- A 5-year average of $43.0 million and a median of $42.7 million in 2019 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2019 and 2021: Convertible Debt grew 8.69% in 2019, then slipped 22.38% in 2021.
- Over 5 years, Convertible Debt stood at $49.4 million in 2017, then fell by 16.08% to $41.4 million in 2018, then grew by 8.69% to $45.0 million in 2019, then fell by 22.16% to $35.1 million in 2020, then advanced by 1.36% to $35.5 million in 2021.
- According to Business Quant data, Convertible Debt over the past three periods registered $35.5 million, $35.1 million, and $42.1 million for Q1 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 35.54 Mn |
| Dec 31, 2020 | 35.07 Mn |
| Sep 30, 2020 | 42.13 Mn |
| Jun 30, 2020 | 46.23 Mn |
| Mar 31, 2020 | 45.79 Mn |
| Dec 31, 2019 | 45.05 Mn |
| Sep 30, 2019 | 44.10 Mn |
| Jun 30, 2019 | 43.18 Mn |
| Mar 31, 2019 | 42.30 Mn |
| Dec 31, 2018 | 41.45 Mn |
| Sep 30, 2018 | 40.63 Mn |
| Jun 30, 2018 | 39.84 Mn |
| Mar 31, 2018 | 39.08 Mn |
| Sep 30, 2017 | 49.39 Mn |
| Jun 30, 2017 | 49.24 Mn |
| Mar 31, 2017 | 49.10 Mn |
| Dec 31, 2016 | 48.96 Mn |
| Sep 30, 2016 | 48.82 Mn |
| Jun 30, 2015 | 8.93 Mn |
| Mar 31, 2015 | 8.67 Mn |